Abstract
Microglia, the tissue macrophages of the brain, have under healthy conditions a resting phenotype that is characterized by a ramified morphology. With their fine processes microglia are continuously scanning their environment. Upon any homeostatic disturbance microglia rapidly change their phenotype and contribute to processes including inflammation, tissue remodeling, and neurogenesis. In this review, we will address functional phenotypes of microglia in diverse brain regions and phenotypes associated with neuroinflammation, neurogenesis, brain tumor homeostasis, and aging.
Keywords: Microglia, aging, gliomas, white matter, grey matter, inflammation, MHC II, TREM2b, LCA, fibronectin, vitronectin, neurohypophysis, amyotrophic lateral, Alzheimer's disease, encephalomyelitis, EAE, prostaglandin, TGF-1, stroke, cyclooxygenase-2, CD86, HLA-DR, activation and complement, astrocytomas, metalloprotease, glioblastomas, Parkinson's disease
CNS & Neurological Disorders - Drug Targets
Title: Microglia Phenotype Diversity
Volume: 10 Issue: 1
Author(s): M. Olah, K. Biber, J. Vinet and H. W.G.M. Boddeke
Affiliation:
Keywords: Microglia, aging, gliomas, white matter, grey matter, inflammation, MHC II, TREM2b, LCA, fibronectin, vitronectin, neurohypophysis, amyotrophic lateral, Alzheimer's disease, encephalomyelitis, EAE, prostaglandin, TGF-1, stroke, cyclooxygenase-2, CD86, HLA-DR, activation and complement, astrocytomas, metalloprotease, glioblastomas, Parkinson's disease
Abstract: Microglia, the tissue macrophages of the brain, have under healthy conditions a resting phenotype that is characterized by a ramified morphology. With their fine processes microglia are continuously scanning their environment. Upon any homeostatic disturbance microglia rapidly change their phenotype and contribute to processes including inflammation, tissue remodeling, and neurogenesis. In this review, we will address functional phenotypes of microglia in diverse brain regions and phenotypes associated with neuroinflammation, neurogenesis, brain tumor homeostasis, and aging.
Export Options
About this article
Cite this article as:
Olah M., Biber K., Vinet J. and W.G.M. Boddeke H., Microglia Phenotype Diversity, CNS & Neurological Disorders - Drug Targets 2011; 10 (1) . https://dx.doi.org/10.2174/187152711794488575
DOI https://dx.doi.org/10.2174/187152711794488575 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemical and Radiochemical Considerations in Radiolabeling with α-Emitting Radionuclides
Current Radiopharmaceuticals The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases
Current Genomics Natural Killer Cells: Prospects in Cancer Immunotherapy
Current Immunology Reviews (Discontinued) Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets In Vitro Evaluation of Antimicrobial and Antiproliferative Activities for Compounds Isolated from the Ficus Bubu Warb. (Moraceae) Fruits: Chemotaxonomic Significance
Drug Delivery Letters Oxidative Stress in Schizophrenia
Current Neuropharmacology Self Assembling Polymers as Polymersomes for Drug Delivery
Current Pharmaceutical Design Radionuclide Therapy of Cancer with Radiolabeled Antibodies
Anti-Cancer Agents in Medicinal Chemistry Advances in Oncolytic Virus Therapy for Glioma
Recent Patents on CNS Drug Discovery (Discontinued) Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Current Cancer Drug Targets Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Mini-Reviews in Medicinal Chemistry Molecular Targeting of Drug Delivery Systems to Cancer
Current Drug Targets Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Interpreting the Mechanisms by which Integrins Promote the Differentiation of Mesenchymal Stem Cells and Integrin Application Prospects
Current Stem Cell Research & Therapy Aquaporin Water Channels in Central Nervous System
Current Neurovascular Research New Strategy Developments in Brain Tumor Therapy
Current Pharmaceutical Design Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment
Current Pharmaceutical Biotechnology Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry Overview of the Structure and Function of Protein Kinases
Current Enzyme Inhibition